《2018年美国肝病学会实践指导：肝细胞癌的诊断、分期和管理》推荐意见摘译

2018-06-08 临床肝胆病杂志.2018.34(6):1181-1182.

美国肝病学会于２０１８年１月更新了肝细胞癌（ＨＣＣ）治疗实践指南，并于２０１８年４月在线发表了该实践指南的指导文件。作为实践指南的补充部分，指导文件旨在更新有关临床管理ＨＣＣ患者的信息。该指导文件适用于大多数患者，但无法取代临床决策。

中文标题：

发布机构：

发布日期：

2018-06-08

简要介绍：

美国肝病学会于２０１８年１月更新了肝细胞癌（ＨＣＣ）治疗实践指南，并于２０１８年４月在线发表了该实践指南的指导文件。作为实践指南的补充部分，指导文件旨在更新有关临床管理ＨＣＣ患者的信息。该指导文件适用于大多数患者，但无法取代临床决策。

译者：锦州医科大学研究生郑可心韩冰(译)，沈阳军区总院消化内祁兴顺郭晓钟（审校）

拓展指南：与肝细胞癌相关指南：

有关肝细胞癌更多指南

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=aa3631c001603641, title=《2018年美国肝病学会实践指导：肝细胞癌的诊断、分期和管理》推荐意见摘译, enTitle=, guiderFrom=临床肝胆病杂志.2018.34(6):1181-1182., authorId=null, author=, summary=美国肝病学会于２０１８年１月更新了肝细胞癌（ＨＣＣ）治疗实践指南，并于２０１８年４月在线发表了该实践指南的指导文件。作为实践指南的补充部分，指导文件旨在更新有关临床管理ＨＣＣ患者的信息。该指导文件适用于大多数患者，但无法取代临床决策。 , cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Fri Jun 08 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>美国肝病学会于２０１８年１月更新了肝细胞癌（ＨＣＣ）治疗实践指南，并于２０１８年４月在线发表了该实践指南的指导文件。作为实践指南的补充部分，指导文件旨在更新有关临床管理ＨＣＣ患者的信息。该指导文件适用于大多数患者，但无法取代临床决策。 </div> <div><br> </div>译者：锦州医科大学研究生郑可心韩冰(译)，沈阳军区总院消化内祁兴顺郭晓钟（审校）<div><br> </div> 拓展指南：<strong>与<font color=red>肝细胞癌</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=0b5341c0015e855e" title="《2018年美国肝病学会肝细胞癌治疗指南》摘译" target=_blank>《2018年美国肝病学会肝细胞癌治疗指南》摘译</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=535c81c0015a692c" title="2018 AASLD指南：肝细胞癌的治疗" target=_blank>2018 AASLD指南：肝细胞癌的治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=9e0951c001a86e54" title="亚太肝细胞癌管理临床实践指南推荐意见（2017年更新版）" target=_blank>亚太肝细胞癌管理临床实践指南推荐意见（2017年更新版）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=c63411c001a859eb" title="《2016年韩国腹部影像学会共识推荐：钆酸增强MRI诊断肝细胞癌》摘译" target=_blank>《2016年韩国腹部影像学会共识推荐：钆酸增强MRI诊断肝细胞癌》摘译</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=df3441c001a568e1" title="2017 APASL亚太临床实践指南：肝细胞癌的管理（更新版）" target=_blank>2017 APASL亚太临床实践指南：肝细胞癌的管理（更新版）</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E8%82%9D%E7%BB%86%E8%83%9E%E7%99%8C" target=_blank>有关肝细胞癌更多指南</a></ul>, tagList=[TagDto(tagId=357, tagName=肝细胞癌)], categoryList=[CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4077, appHits=201, showAppHits=6, pcHits=2983, showPcHits=1258, likes=110, shares=1, comments=11, approvalStatus=1, publishedTime=Fri Jun 15 00:35:13 CST 2018, publishedTimeString=2018-06-08, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Jun 15 00:35:13 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 20:49:32 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=《2018年美国肝病学会实践指导：肝细胞癌的诊断、分期和管理》推荐意见摘译)])

《2018年美国肝病学会实践指导：肝细胞癌的诊断、分期和管理》推荐意见摘译

下载请点击：

评论区 (11)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=324899, encodeId=cf793248991e, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sun Jun 17 09:49:48 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324481, encodeId=37b03244815d, content=学习了谢谢分享学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Jun 15 22:49:26 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324384, encodeId=0b553243849e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ac82155377, createdName=1201e5c5m39暂无昵称, createdTime=Fri Jun 15 09:23:25 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324374, encodeId=f0a63243e441, content=一起学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Fri Jun 15 08:56:48 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324365, encodeId=ee56324365ad, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Fri Jun 15 08:42:32 CST 2018, time=2018-06-15, status=1, ipAttribution=)]
2018-06-17 131****1460

学习了受益匪浅

107 0
[GetPortalCommentsPageByObjectIdResponse(id=324899, encodeId=cf793248991e, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sun Jun 17 09:49:48 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324481, encodeId=37b03244815d, content=学习了谢谢分享学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Jun 15 22:49:26 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324384, encodeId=0b553243849e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ac82155377, createdName=1201e5c5m39暂无昵称, createdTime=Fri Jun 15 09:23:25 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324374, encodeId=f0a63243e441, content=一起学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Fri Jun 15 08:56:48 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324365, encodeId=ee56324365ad, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Fri Jun 15 08:42:32 CST 2018, time=2018-06-15, status=1, ipAttribution=)]
2018-06-15 大爰

学习了谢谢分享学习!

90 0
[GetPortalCommentsPageByObjectIdResponse(id=324899, encodeId=cf793248991e, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sun Jun 17 09:49:48 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324481, encodeId=37b03244815d, content=学习了谢谢分享学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Jun 15 22:49:26 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324384, encodeId=0b553243849e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ac82155377, createdName=1201e5c5m39暂无昵称, createdTime=Fri Jun 15 09:23:25 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324374, encodeId=f0a63243e441, content=一起学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Fri Jun 15 08:56:48 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324365, encodeId=ee56324365ad, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Fri Jun 15 08:42:32 CST 2018, time=2018-06-15, status=1, ipAttribution=)]
2018-06-15 1201e5c5m39暂无昵称

学习了

88 0
[GetPortalCommentsPageByObjectIdResponse(id=324899, encodeId=cf793248991e, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sun Jun 17 09:49:48 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324481, encodeId=37b03244815d, content=学习了谢谢分享学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Jun 15 22:49:26 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324384, encodeId=0b553243849e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ac82155377, createdName=1201e5c5m39暂无昵称, createdTime=Fri Jun 15 09:23:25 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324374, encodeId=f0a63243e441, content=一起学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Fri Jun 15 08:56:48 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324365, encodeId=ee56324365ad, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Fri Jun 15 08:42:32 CST 2018, time=2018-06-15, status=1, ipAttribution=)]
2018-06-15 wzb521zf

一起学习学习

83 0
[GetPortalCommentsPageByObjectIdResponse(id=324899, encodeId=cf793248991e, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sun Jun 17 09:49:48 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324481, encodeId=37b03244815d, content=学习了谢谢分享学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Jun 15 22:49:26 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324384, encodeId=0b553243849e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ac82155377, createdName=1201e5c5m39暂无昵称, createdTime=Fri Jun 15 09:23:25 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324374, encodeId=f0a63243e441, content=一起学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Fri Jun 15 08:56:48 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324365, encodeId=ee56324365ad, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Fri Jun 15 08:42:32 CST 2018, time=2018-06-15, status=1, ipAttribution=)]
2018-06-15 龙胆草

学习谢谢分享

80 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

指南&解读指南

《2018年美国肝病学会实践指导：肝细胞癌的诊断、分期和管理》推荐意见摘译

相关指南

科室

工具

服务